Measles-Mumps-Rubella Vaccine - Adverse effects
Research News and Information

Sunday, November 22, 2009

A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk.

24 Jul 2009 Viral infections are probably involved in the pathogenesis of multiple sclerosis (MS). A recent cohort study in the Gothenburg population revealed no change in MS incidence associated with the introduction of the Swedish measles, mumps and rubella ... Read more...

Safety of a refrigerator-stable varicella vaccine (VARIVAX) in healthy 12- to 15-month-old children: A randomized, double-blind, cross-over study.

21 Jul 2009 The safety of a single injection of the refrigerator-stable formulation of varicella vaccine VARIVAX was assessed in a blind, randomized, cross-over trial. Five hundred seven healthy children aged 12 to 15 months received subcutaneous injections of ... Read more...

Autism and vaccination-the current evidence.

29 Jun 2009 PURPOSE: The purpose of this article is to review relevant background literature regarding the evidence linking thimerosal-containing vaccine and the measles, mumps, and rubella vaccine to autism. CONCLUSIONS: Rigorous scientific studies have not ... Read more...

Latest indexed articles for 'Measles-Mumps-Rubella Vaccine - Adverse effects'

These are the very latest articles for this heading:

• A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk. 24 Jul 2009
• Safety of a refrigerator-stable varicella vaccine (VARIVAX) in healthy 12- to 15-month-old children: A randomized, double-blind, cross-over study. 21 Jul 2009
• Autism and vaccination-the current evidence. 29 Jun 2009
• Vaccine disputes. 20 Jun 2009
• A new, rapid, and promising approach to aerosol immunization: inflatable bags and valved masks. 15 Jun 2009
• Litigation, regulation, and education--protecting the public's health through childhood immunization. 9 Jun 2009
• When vaccine injury claims go to court. 9 Jun 2009
• Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. 7 Jun 2009
• Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro) and a varicella vaccine (VARIVAX) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial. 12 Apr 2009
• Anatomy of a scare. 28 Feb 2009
• Acute-onset madarosis following MMR vaccination. 27 Feb 2009
• Routine vaccination against pertussis and the risk of childhood asthma: a population-based cohort study. 27 Feb 2009
• Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age. 22 Feb 2009
• The rise in autism and the mercury myth. 30 Jan 2009
• [Lack of association between MMR vaccination and the incidence of autism in children: a case-control study] 30 Dec 2008
• Autism spectrum disorders: prevalence and vaccines. 30 Dec 2008
• There is no evidence that . . . 30 Dec 2008
• Efficacy and safety of measles, mumps, rubella and varicella live viral vaccines in transplant recipients receiving immunosuppressive drugs. 21 Dec 2008
• Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations. 20 Dec 2008
• Autism and vaccinations: is there a correlation? 29 Nov 2008

See a longer list of these articles.

Technical information about 'Measles-Mumps-Rubella Vaccine'

Definition: A combined vaccine used to prevent MEASLES; MUMPS; and RUBELLA.

Registry Number: 0

Descriptor UI: D022542

Alternative terms: Measles-Mumps-Rubella Vaccine; Measles Mumps Rubella Vaccine; Vaccine, Measles-Mumps-Rubella; MMR Vaccine; Vaccine, MMR; Mumps-Measles-Rubella Vaccine; Mumps Measles Rubella Vaccine; Vaccine, Mumps-Measles-Rubella; Measles, Mumps, Rubella Vaccine; Triviraten Berna; Berna, Triviraten; Priorix; Trimovax; Virivac; Pluserix;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D20.215.894.815.500; D20.215.894.899.390; D20.215.894.899.404.500; D20.215.894.899.488.500; D20.215.894.899.779.500;

History Note: 2001; use MEASLES-MUMPS-RUBELLA VACCINE (NM) to search MEASLES, MUMPS, RUBELLA VACCINE 1986-2000